No verified last-24-hours biotechnology news was provided in the search results, so a strictly sourced market analysis cannot be written without risking unsupported claims.
Because the prompt requires real events from the past 24 hours and the available search results are empty, I cannot responsibly identify a trending biotech catalyst, quantify its impact, or attribute moves in biotech shares, clinical pipelines, or regulatory policy to a specific news item.
If you want, I can draft the article once fresh search results are available, or I can produce a clearly labeled template for a biotech market note that you can populate with verified headlines, company names, trial data, and stock reactions.
